Another under-$10 name that's starting to trend within range of triggering a major breakout trade is Protalix BioTherapeutics ( PLX), which is engaged in the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system. This stock is off to a decent start in 2013, with shares up 8.2%. If you take a look at the chart for Protalix BioTherapeutics, you'll notice that this stock is just starting to bounce off its 200-day moving average of $5.44 a share, and it's just starting to flirt with its 50-day moving average of $5.61 a share. This move is quickly pushing PLX above a near-term downtrend line and it's moving the stock within range of triggering a major breakout trade. Market players should now look for long-biased trades in PLX if it manages to break out above some near-term overhead resistance levels at $5.74 to $5.98 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 341,921 shares. If that breakout triggers soon, then PLX will set up to re-test or possibly take out its next major overhead resistance level at $6.73 a share. Any high-volume move above $6.73 to $6.80 will then put $7.70 into range for shares of PLX. Traders can look to buy PLX off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of $5.44 a share or near some key near-term support at $5.40 a share. One could also buy PLX off strength once it takes out those breakout levels with volume and then simply use a stop right below its 50-day at $5.62 or its 200-day at $5.44 a share.